Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight (MIntS)

November 5, 2018 updated by: Dr. Michael Chourdakis

The purpose of this study is to test whether the provision of ONS to malnourished children across Europe, in addition to standard counselling, will improve weight gain and other outcomes.

The hypothesis to be tested is:

• Supplementation with ONS in malnourished paediatric patients will lead to increased WFH gain, as well as less malnutrition related complications (e.g. infections).

Primary outcome • The change in BMI z-score over the intervention period of 3 months

Secondary outcomes

• The change in WFH-weight for height (z-scores) over the intervention period of 3 months

Study Overview

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussel, Belgium
        • UZ Brussel
      • Zagreb, Croatia
        • Children's Hospital Zagreb
      • Lille, France
        • Hospital Jeanne de Flandre, Pediatrics Department, CHRU
      • Tours, France, 37000
        • CHU Tours
      • Athens, Greece
        • Agia Sofia Children's Hospital
      • Thessaloniki, Greece, 54124
        • Aristotle University Of Thessaloniki, School of Medicine
      • Thessaloniki, Greece
        • 1st Paediatric Dept, Hippokration Hospital, AUTH
      • Thessaloniki, Greece
        • 3rd Paediatric Dept, Hippokration Hospital, AUTH
      • Tehran, Iran, Islamic Republic of, 1419733151
        • Tehran University of Medical Sciences Tehrān, Children Medical Center
      • Tehran, Iran, Islamic Republic of
        • Mofid Children Hospital
      • Oslo, Norway
        • Department of Pediatrics, Women and Children's Division, Oslo University Hospital
      • Warszawa, Poland, 01-184
        • Medical University of Warsaw
      • Warszawa, Poland, 04-730
        • The Children's Memorial Health Institute
      • Moscow, Russian Federation, 125480
        • Russian Medical Academy of Postgraduate Education
    • Respublika Tatarstan
      • Kazan, Respublika Tatarstan, Russian Federation, 420012
        • Kazan State Medical University
      • Ankara, Turkey
        • Ankara University School of Medicine
      • Ankara, Turkey, 06100
        • Hacettepe University, Ankara
      • Inönü, Turkey
        • Inönü University School of Medicine
    • Inciralti-izmir
      • Izmir, Inciralti-izmir, Turkey, 35340
        • Dokuz Eylul University,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Children treated at the participating paediatric centres during the study period (inpatients or outpatients)
  2. Age between 24 months to 12 years at inclusion
  3. WFH at inclusion <- 1,5 SD - >-2,5 SD (based on WHO) OR Decrease in WFH z-score of ≥1 SD within the last 3 months, and underlying disease with high risk of undernutrition
  4. Children who would be considered candidates for oral nutrition intervention (but do not need tube feeding)
  5. Written informed consent of parents/caregivers

Exclusion Criteria:

  1. Children in need of intensive care
  2. Inability to consume ONS (e.g. major gastrointestinal dysfunction)
  3. Children, for whom normal nutrition intervention would be inappropriate (e.g. food intolerance, allergy)
  4. Use of parenteral feeding and/or enteral tube-feeding
  5. Severe edema (>0.5 cm pitting edema on the dorsum of the foot)
  6. Participation in another intervention study involving investigational or marketed products concomitantly or within two weeks prior to entry into the trial.
  7. Children having received enteral nutrition treatment for underweight in the previous month
  8. Oncology patients during chemo-, radio-therapy
  9. Expected hospital stay at inclusion longer than 7 days

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oral Nutritional Supplement (ONS)
Diet consultation for the child/family + ONS
The ONS provided to the children intervention group will be a ready to drink age adapted oral nutrition supplement providing 1,5 kcal/ml
No Intervention: No Oran Nutritional Supplement (ONS)
Diet consultation for the child/family

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI z-score
Time Frame: 3 months
The change in BMI z-score over the intervention period of 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight change
Time Frame: 3 months
The change in WFH-weight for height (z-scores) over the intervention period of 3 months
3 months
Infectious complications
Time Frame: 3 months
Frequency of infectious complications (number of days with temperature >38,5°C, number of infections requiring antibiotic use)
3 months
Hospital admissions
Time Frame: 3 months
Admission for hospital inpatient treatments (number of days of hospital stay, number of admissions)
3 months
Gastrointestinal complications
Time Frame: 3 months
Frequency of gastrointestinal complications (number of days with diarrhoea/vomiting as reported by carers). Other GI symptoms could be recorded, as potential reason for lower food intake
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2015

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

March 2, 2015

First Submitted That Met QC Criteria

March 4, 2015

First Posted (Estimate)

March 9, 2015

Study Record Updates

Last Update Posted (Actual)

November 6, 2018

Last Update Submitted That Met QC Criteria

November 5, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AUTh112Med

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disease Associated Underweight

Subscribe